全球新药研发项目交易情况分析

Introduction of global R&D project deal of new drugs

新药研发项目交易对企业的"情绪"和制药行业的整体状况具有重大意义。本文对截至2009年第3季度的医药企业研发项目交易量排名情况、交易涉及的热点治疗领域以及不同研发阶段的交易情况进行分析,同时指出医药行业的现状:大型制药企业通过交易寻求混合的商业模式,从而实现利润最大化;小分子药物重新受到关注,交易量呈上升趋势;以及非核心资产的剥离。

Deals speak volumes about company sentiment and the overall health of the pharmaceutical industry.The rank-ing of the pharmaceutical industry＇s most large dealmakers,hot therapy areas centered-deals,and the deal profile of differ-ent study stages to the first three quarters of 2009 were reviewed in this paper.In the meantime,the pharmaceutical status quo of the RD climate was pointing out：pursuing the hybrid model to maximize the profit;small-molecule drugs was re-gaining popularity with increase in small-molecule-focused deals;and the divestiture of the non-nuclear assets.